COVID-19 PANDEMİSİNDE TİP 1 DİABETES MELLİTUSLU ÇOCUKLARIN KARŞILAŞTIĞI ZORLUKLARIN DEĞERLENDİRİLMESİ

Year 2024, Volume: 25 Issue: 3, 281 - 288, 18.07.2024

Ayşe Güngör , Ayşegül Bükülmez

https://doi.org/10.18229/kocatepetip.1375129

Abstract

AMAÇ: Bu çalışma ile Tip 1 Diabetes Mellitus tanılı çocuk hastaların ve ailelerinin COVID-19 pandemisi sırasında yaşadıkları zorlukların değerlendirilmesi amaçlandı.
GEREÇ VE YÖNTEM: Bu çalışma Afyonkarahisar Sağlık Bilimleri Üniversitesi Hastanesi Çocuk Sağlığı ve Hastalıkları Kliniği’nde 1 Mayıs 2020 - 1 Temmuz 2020 tarihleri arasında yürütüldü. Çalışmaya 4-18 yaş arası Tip 1 Diabetes Mellitus tanısı ile takip edilen 102 hasta ve ebeveyn çifti dahil edildi. Tüm veriler, “Google Formlar” platformu aracılığıyla online anket yöntemiyle toplandı. İstatistiksel analiz için SPSS 26 paket programı kullanıldı ve p<0,05 anlamlı kabul edildi.
BULGULAR: Çalışmaya alınan hastaların 55’i kız (%53.9) ve 47’si ise erkek idi. Çalışmaya katılan hastaların yaş ortalaması 13.02 ±3.9 yıl olarak bulundu. Pandemi döneminde katılımcı olguların 62’sinin (%60,8) insülin tedavi dozunda artış olduğu, 21’inin (%20,6) hiperglisemi atağı, 61’inin (%59,8) hipoglisemi atağı yaşadığı saptandı. Olguların 44’ünün (%43.1) abur-cubur tüketiminin arttığı ve 60’nın (%58,8) uyku alışkanlığının etkilendiği bulundu.
SONUÇ: Bu çalışma, Diabetes Mellitus tanılı çocukları olan ebeveynlerin pandemi döneminde COVID-19 hakkında yeterli bilgiye sahip olduklarını gösterdi. Ayrıca pandemi sürecinde Tip 1 Diabetes Mellitus tanısı alan hastaların diyetlerine uyum sorunları yaşadıkları, uyku düzenlerinin değiştiği ve hastalığı kontrol altında tutabilmek için profesyonel sağlık desteğine ihtiyaç duydukları belirlendi.

Keywords

Diabetes Mellitus, COVID-19, Pandemi, Çocuk.

Ethical Statement

Bu çalışma için Afyonkarahisar Sağlık Bilimleri Üniversitesi Etik Kurul Başkanlığı’ndan onay alınmıştır (Tarih: 05.06.2020, Karar No:2020/260)

EVALUATION OF THE CHALLENGES FACED BY CHILDREN WITH TYPE 1 DIABETES MELLITUS DURING THE COVID-19 PANDEMIC

Abstract

OBJECTIVE: This study aimed to evaluate the difficulties experienced by pediatric patients diagnosed with Type 1 Diabetes Mellitus and their families during the COVID-19 pandemic.
MATERIAL AND METHODS: This study was conducted at the Afyonkarahisar Health Sciences University Hospital Child Health and Diseases Clinic between May 1, 2020 and July 1, 2020. 102 patients and their parent pairs, aged between 4 and 18, diagnosed with Type 1 Diabetes Mellitus, were included in the study. All data were collected by an online survey method through the "Google Forms" platform. The SPSS 26 package program was used for statistical analysis and p<0.05 was considered significant.
RESULTS: Of the patients included in the study, 55 were female (53.9%) and 47 were male. The average age of the patients participating in the study was found to be 13.02 ±3.9 years. It was determined that during the pandemic period, 62 (60.8%) of the participating cases had an increase in their insulin treatment dose, 21 (20.6%) experienced a hyperglycemia attack, and 61 (59.8%) experienced a hypoglycemia attack. It was found that junk food consumption increased in 44 (43.1%) of the cases and the sleeping habits of 60 (58.8%) were affected.
CONCLUSIONS: This study showed that parents of children diagnosed with Diabetes Mellitus had sufficient knowledge about COVID-19 during the pandemic. During the pandemic, it was also determined that patients diagnosed with Type 1 Diabetes Mellitus had problems adapting to their diet, their sleep patterns changed and they needed professional health support to keep the disease under control.

Keywords

Diabetes Mellitus, COVID-19, Pandemics, Children

References

• 1. Prosperi S, Chiarelli F. COVID-19 and diabetes in children. Annals of Pediatric Endocrinology & Metabolism. 2022;27(3):157-68.
• 2. International Committee on Taxonomy Viruses, Naming the 2019 Coronavirus. (2020). Available from: https://talk.ictvonline.org/ (Accessed date: May 11, 2021).
• 3. World Health Organization, Naming the Coronavirus Disease (COVID-19) and the Virus That Causes It. (2020). Available from: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019/technical- guidance/naming-the-coronavirus-disease-(COVID-2019)-and-thevirus-that-causes-it (Accessed date: July 6, 2021).
• 4. Zimmermann P, Curtis N. Coronavirus infection in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355-68.
• 5. American Academy of Pediatrics (August 2021). Children and COVID-19: state level data report. Erişim tarihi: 08.11.2022 https://www. aap.org/en/pages/2019-novel-coronavirus-COVID-19-infections/children- and-COVID-19-state-level-data-report/. Erişim tarihi: 08.11.20226.
• 6. Cui X, Zhao Z, Zhang T, et al. A systemic review and metaanalysis of children with coronavirus disease 2019 (COVID-19). J Med Virol. 2021;93(2):1057-69.
• 7. Zacharia P, Jonhson CL, Halabi KC, Ahn D, Sen AI, Fisher A, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in children’s hospital in New York City, New York. JAMA Pediatr. 2020;174:202430.
• 8. Lin X, Xu Y, Pan X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):14790.
• 9. Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 2020;68(1):2-5.
• 10. Rezaei N, Montazeri F, Malekpour MR, et al. COVID-19 in patients with diabetes: factors associated with worse outcomes. J Diabetes Metab Disord. 2021;20(2):1605-14.
• 11. Rabbone I, Schiaffini R, Cherubini V, Maffeis C, Scaramuzza A; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care. 2020;43(11):2870-2.
• 12. Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020;8(10):782-92.
• 13. Demir K, Özen S, Konakçı E, Aydın M, Darendeliler F. A Comprehensive Online Calculator for Pediatric Endocrinologists: ÇEDD Çözüm/TPEDS Metrics. J Clin Res Pediatr Endocrinol. 2017;9(2):182-4.
• 14. Pal R, Yadav U, Verma A, Bhadada SK. Awareness Regarding COVID-19 And Problems Being Faced By Young Adults With Type 1 Diabetes Mellitus Amid Nationwide Lockdown İn India: A Qualitative İnterview Study. Prim Care Diabetes. 2021;15(1):10-5.
• 15. Bükülmez A, Baş MT, Çiftci E. Evaluation Of Anti-COVID-19 Measures Taken By The Parents Of Children With Celiac Disease: A Cross-Sectional Study. Sao Paulo Med J. 2021;139(3):201-9.
• 16. Braveman P. Accumulating Knowledge On The Social Determinants Of Health And İnfectious Disease. Public Health Rep. 2011;126(3):28-30.
• 17. Zhong BL, Luo W, Li HM, et al. Knowledge, Attitudes, And Practices Towards COVID-19 Among Chinese Residents During The Rapid Rise Period Of The COVID-19 Outbreak: A Quick Online Cross-Sectional Survey. Int J Biol Sci. 2020;16(10):1745-52.
• 18. Tural E. COVID-19 Pandemi Dönemi Ev Karantinasında Fiziksel Aktivite Düzeyinin Yaşam Kalitesine Etkisi. Van Sağlık Bilimleri Dergisi. 2020;13 (Özel Sayı):10-8.
• 19. Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. Diabetes Metab Syndr. 2020;14(6):1815-9.
• 20. Moreno-Fernández J, García-Seco JA, Rodrigo EMO, Segura AMS, García-Seco F, Muñoz-Rodríguez JR. Vaccination Adherence to Influenza, Pneumococcal and Hepatitis B Virus in Adult type 1 diabetes mellitus patients. Prim Care Diabetes. 2019;14(4):343-8.
• 21. Almusalam YA, Ghorab MK, Alanezi SL. Prevalence of Influenza and Pneumococcal Vaccine Uptake in Saudi Type 2 Diabetic Individuals. J Family Med Prim Care. 2019;8(6):2112-9.
• 22. Erbay A, Kader Ç, Ede H, et al. Yozgat Bozok Üniversitesi Araştırma ve Uygulama Hastanesi’ne Başvuran Risk Gruplarında ve ≥65 Yaşındaki Erişkinlerde İnfluenza ve Pnömokok Aşılanma Durumu. Klimik. 2018;31(3):205-9.
• 23. Cicero A, Fogacci F, Giovanini M, Mezzadri M, Grandi E. COVID-19-Related Quarantine Effect on Dietary Habits in a Northern Italian Rural Population: Data from the Brisighella Heart Study. Nutriens. 2021;13(2):309- 319.
• 24. Bodur G, Keser A, Şıklar Z, Berberoğlu M. Tip 1 Diyabetli Adölesanların Diyet Kalitesini Etkileyen Faktörler Üzerine Kesitsel Bir Araştırma. İstanbul Tıp Fakültesi Dergisi. 2021;84(4):552-8.
• 25. American Diabetes Association/ADA. 4. Lifestyle Management: Standards of Medical Care in Diabetes- 2018. Diabetes Care. 2018;41(1):38-50.
• 26. Muscogiuri G, Barrea L, Savastano S, Colao A. Nutritional Recommendations for CoVID-19 Quarantine. Eur J Clin Nutr. 2020;74(6):850–1.
• 27. Pietrobelli A, Pecoraro L, Ferruzzi A, et al. Effects of COVID-19 Lockdown on Lifestyle Behaviors in Children with Obesity Living in Verona, Italy: A Longitudinal Study. Obesity. 2020;28(8):1382–5.
• 28. Sher L. COVID-19, Anxiety, Sleep Disturbances And Suicide. Sleep Medicine. 2020;70:124.
• 29. Aslan B, Saka M. Tip 1 Diyabetli Adölesan Bireylerde Uyku Kalitesi ve Beslenme Durumu Arasındaki İlişkinin Belirlenmesi. Journal Of Health Scıences. 2020;29(1):7-13.
• 30. Bhat S, Chokroverty S. Sleep Disorders and COVID-19. Sleep Medicine 2021;91:253-61.
• 31. Pla B, Arranz A, Knott C, et al. Impact Of COVID-19 Lockdown On Glycemic Control İn Adults With Type 1 Diabetes Mellitus. J Endocr Soc. 2020;4(12):1-8.
• 32. Ekim A.Tip 1 Diyabetli Çocukların Yaş Dönemlerine Göre İnsülin Uygulama Becerileri. Yüksek Lisans Tezi. İstanbul:Marmara Üniversitesi Sağlık Bilimleri Enstitüsü, Çocuk Sağlığı ve Hastalıkları Hemşireliği Anabilim Dalı, 2007.
• 33. Ruiz De Adana MS, Alhambra-Expósito MR, Muñoz-Garach A, et al. Randomized Study To Evaluate The Impact Of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses Of Insulin And Suboptimal Hba1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2020;43(2):337-42.
• 34. Alromaihi D, Alamuddin N, George S. Sustainable Diabetes Care Services During COVID-19 Pandemic. Diabetes Research and Clinical Practice. 2020;166:108298.
• 35. Banerjee M, Chakraborty S, Pal R. Diabetes Self-Management Amid COVID-19 Pandemic. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):351-4.
• 36. Griffith M, Siminerio L, Payne T, Krall J. A Shared Decision-Making Approach To Telemedicine: Engaging Rural Patients İn Glycemic Management. J Clin Med. 2016;5(11): 103.
• 37. Predieri B, Leo F, Candia F, et al. Glycemic Control Improvement İn Italian Children And Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due To The COVID-19 Pandemic. Front Endocrinol (Lausanne). 2020;11:595735.